Superacid-Synthesized Fluorinated Diamines Act as Selective hCA IV Inhibitors

Carbonic anhydrase (CA) IV is a membrane-bound enzyme involved in important physio-pathological processes, such as excitation-contraction coupling in heart muscle, central nervous system (CNS) extracellular buffering, and mediation of inflammatory response after stroke. Known since the mid-1980s, this isoform is still largely unexplored when compared to other isoforms, mostly for the current lack of inhibitors targeting selectively this isoform. The discovery of selective CA IV inhibitors is thus largely awaited. In this work, we report β-(di) fluoropropyl diamines as effective CA IV inhibitors, opening real perspectives for a new mode of selective inhibition of this isoform. Inhibition data reveal that the essential structure core to ensure a potent and selective inhibition of CA IV is the <i>N</i>-propyldiamine. Molecular modeling studies were employed to understand the binding mode of the synthesized amines. Conformational searches within the active site space carried out in an implicit solvent (water) model were also conducted.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2024-10-24
DOI
https://doi.org/10.1021/acs.jmedchem.4c01795
Citations
5
Primary Topic
Enzyme function and inhibition
Type
article
Field-Weighted Citation Impact
1.17

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Superacid-Synthesized Fluorinated Diamines Act as Selective hCA IV Inhibitors

Alessio Nocentini, Emanuela Berrino, Claudiu T. Supuran, Paola Gratteri et al.
5 citations
Journal of Medicinal Chemistry
Enzyme function and inhibition
1.17
article

Superacid-Synthesized Fluorinated Diamines Act as Selective hCA IV Inhibitors

Alessio Nocentini, Emanuela Berrino, Claudiu T. Supuran, Paola Gratteri, Bastien Michelet, Sébastien Thibaudeau, Fabrizio Carta, Agnès Martin‐Mingot, Gianluca Bartolucci, Kassandra Vitse
article en
5 citations

Abstract

Carbonic anhydrase (CA) IV is a membrane-bound enzyme involved in important physio-pathological processes, such as excitation-contraction coupling in heart muscle, central nervous system (CNS) extracellular buffering, and mediation of inflammatory response after stroke. Known since the mid-1980s, this isoform is still largely unexplored when compared to other isoforms, mostly for the current lack of inhibitors targeting selectively this isoform. The discovery of selective CA IV inhibitors is thus largely awaited. In this work, we report β-(di) fluoropropyl diamines as effective CA IV inhibitors, opening real perspectives for a new mode of selective inhibition of this isoform. Inhibition data reveal that the essential structure core to ensure a potent and selective inhibition of CA IV is the <i>N</i>-propyldiamine. Molecular modeling studies were employed to understand the binding mode of the synthesized amines. Conformational searches within the active site space carried out in an implicit solvent (water) model were also conducted.

Journal of Medicinal ChemistryVol. 67(21)
Centre National de la Recherche Scientifique (FR), Université de Poitiers (FR), Institut de Chimie des Milieux et des Matériaux de Poitiers (FR), University of Florence (IT)
European Commission, Centre National de la Recherche Scientifique, Université de Poitiers, European Regional Development Fund
Openalex Percentile: Top 21%
Enzyme function and inhibition
1.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.